Subjects were required to perform two tasks, while being shown visual tobacco cues as well as neutral images, and were rated throughout on levels of “withdrawal, craving, side effects, heart rate, and blood pressure.”
Researchers found that subjects that received a placebo had more bias toward the tobacco image cues compared to neutral images, while those that received 800mg of CBD showed neutral response to the tobacco cues.
In conclusion, researchers said, “A single 800‐mg oral dose of cannabidiol reduced the salience and pleasantness of cigarette cues, compared with placebo, after overnight cigarette abstinence in dependent smokers. Cannabidiol did not influence tobacco craving or withdrawal or any subjectively rated side effects.”
While results did not indicate that CBD decreased cravings or withdrawal, researchers found subjects that received responded with “reduced explicit pleasantness of cigarette images,” as well as having decreased systolic blood pressure during abstinence.
The study was authored by Chandni Hindocha Tom P. Freeman Meryem Grabski Jack B. Stroud Holly Crudgington Alan C. Davies Ravi K. Das William Lawn Celia J. A. Morgan H. Valerie Curran.
(Photo courtesy Lindsay Fox/ECigaretteReviewed.com)
Read more from the source…
Source: MG Retailer
Photo: Lindsay Fox, eCigaretteReviewed.com